Combination of companion animal distribution, production animal distribution and technology platforms will make animal healthcare more accessible and affordable ...
Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500 million aggregate principal amount of its 3.950% Senior Notes due February 13, 2029 (the “2029 Notes”), $500 million...
Cencora, Azenta, The Pennant Group, LifeStance Health Group, and Gilead Sciences Shares Are Soaring, What You Need To Know
1 Momentum Stock with Impressive Fundamentals and 2 We Question
5 Revealing Analyst Questions From Cencora’s Q4 Earnings Call
Cencora, Inc. (NYSE: COR) today announced that it priced $500 million aggregate principal amount of its 3.950% Senior Notes due February 13, 2029 (the “2029 Notes”), $500 million aggregate principal...
/Cencora%20Inc_%20chart%20on%20phone-by%20T_Schneider%20via%20Shutterstock.jpg)
Cencora has consistently outperformed the broader market over the past year, and analysts are maintaining a strongly bullish outlook on the company’s growth and earnings potential.
COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts
The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed down -0.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.53%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.77%. March E-mini...